Sentinel node tumor burden in prediction of prognosis in melanoma patients

Autor: Juha Jernman, Leea Ylitalo, Niina Korhonen, Johanna Palve, Tiina Luukkaala
Přispěvatelé: Lääketieteen ja terveysteknologian tiedekunta - Faculty of Medicine and Health Technology, Yhteiskuntatieteiden tiedekunta - Faculty of Social Sciences, Tampere University, HUS Inflammation Center, Clinicum, Department of Dermatology, Allergology and Venereology
Rok vydání: 2020
Předmět:
Male
Oncology
Cancer Research
Skin Neoplasms
CUTANEOUS MELANOMA
MULTICENTER
0302 clinical medicine
Surgical oncology
030212 general & internal medicine
DISSECTION
Melanoma
Lymph node
Hematology
General Medicine
Middle Aged
Sentinel node
Prognosis
POSITIVE MELANOMA
Tumor Burden
3. Good health
Dissection
medicine.anatomical_structure
Chemotherapy
Adjuvant

Lymphatic Metastasis
030220 oncology & carcinogenesis
BIOPSY
Female
Sentinel Lymph Node
Sentinel node-positive
Research Paper
medicine.medical_specialty
3122 Cancers
Risk Assessment
03 medical and health sciences
Syöpätaudit - Cancers
Internal medicine
Prognosis in melanoma
medicine
Adjuvant therapy
Humans
TRUNK
Aged
Proportional Hazards Models
Retrospective Studies
Sentinel node tumor burden
Sentinel Lymph Node Biopsy
business.industry
Retrospective cohort study
medicine.disease
Lymph Node Excision
business
Follow-Up Studies
Zdroj: Clinical & Experimental Metastasis
ISSN: 1573-7276
0262-0898
Popis: Recent data have demonstrated no survival benefit to immediate completion lymph node dissection (CLND) for positive sentinel node (SN) disease in melanoma. It is important to identify parameters in positive SNs, which predict prognosis in melanoma patients. These might provide prognostic value in staging systems and risk models by guiding high-risk patients’ adjuvant therapy in clinical practice. In this retrospective study of university hospital melanoma database we analyzed tumor burden and prognosis in patients with positive SNs. Patients were stratified by the diameter of tumor deposit, distribution of metastatic focus in SN, ulceration and number of metastatic SNs. These were incorporated in Cox proportional hazard regression models. Predictive ability was assessed using Akaike information criterion and Harrell’s concordance index. A total of 110 patients had positive SN and 104 underwent CLND. Twenty-two (21%) patients had non-SN metastatic disease on CLND. The 5-year melanoma specific survival for CLND-negative patients was 5.00 years (IQR 3.23–5.00, range 0.72–5.00) compared to 3.69 (IQR 2.28–4.72, range 1.01–5.00) years in CLND-positive patients (HR 2.82 (95% CI 1.17–6.76, p = 0.020).The models incorporating distribution of metastatic focus and the largest tumor deposit in SN had highest predictive ability. According to Cox proportional hazard regression models, information criterions and c-index, the diameter of tumor deposit > 4 mm with multifocal location in SN despite of number of metastatic SN were the most important parameters. According to the diameter of tumor deposit and distribution of metastatic focus in SN, adequate stratification of positive SN patients was possible and risk classes for patients were identified.
Databáze: OpenAIRE